Robert F. Kennedy Jr.’s nomination to be health secretary advances in divided Senate committee vote
WASHINGTON — A Senate panel divided starkly along partisan lines voted on Tuesday to advance the nomination of Robert F.
Merck price target lowered to $106 from $113 at Morgan Stanley
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $106 from $113 and keeps an Equal Weight rating on the ...
STAT5h
Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
Merck pessimistic about 2025
Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...
Stock Market Today: Earnings Speak Louder Than Tariffs
"The blended (year-over-year) earnings growth rate for the S&P 500 is 13.2%," notes FactSet Senior Earnings Analyst John Butters. "If 13.2% is the actual growth rate for the quarter, it will mark the ...
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
S&P 500, Nasdaq climb on strong gains from Palantir; PepsiCo and Merck shares slip, while Ford rises
The Nasdaq Composite and S&P 500 rose on Tuesday due to strong gains from Palantir as market focused on latest trade news.
Why Merck Stock Is Plummeting Today
Merck's stock sank after the company reported fourth-quarter and year-end 2024 earnings this morning. Although it narrowly ...
Merck's Keytruda Dominance and a Strong Oncology Pipeline Help Support Merck's Wide Moat
Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...